1Y2F

Crystal Structure of ZipA with an inhibitor

1Y2F の概要

• エントリーDOI: 10.2210/pdb1y2f/pdb
• 関連するPDBエントリー: 1Y2G
• 分子名称: Cell division protein zipA, 4-{2-[4-(2-AMINOETHYL)PIPERAZIN-1-YL]PYRIDIN-4-YL}-N-(3-CHLORO-4-METHYLPHENYL)PYRIMIDIN-2-AMINE (3 entities in total)
• 機能のキーワード: cell cycle
• 由来する生物種: Escherichia coli
• 細胞内の位置: Cell inner membrane; Single-pass type I membrane protein: P77173
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 15957.61

構造登録者

Mosyak, L.,Rush, T.S. (登録日: 2004-11-22, 公開日: 2005-03-01, 最終更新日: 2023-08-23)

主引用文献

Rush, T.S.,Grant, J.A.,Mosyak, L.,Nicholls, A.
A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction
J.Med.Chem., 48:1489-1495, 2005

PubMed Abstract: In this paper, we describe the first prospective application of the shape-comparison program ROCS (Rapid Overlay of Chemical Structures) to find new scaffolds for small molecule inhibitors of the ZipA-FtsZ protein-protein interaction, a proposed antibacterial target. The shape comparisons are made relative to the crystallographically determined, bioactive conformation of a high-throughput screening (HTS) hit. The use of ROCS led to the identification of a set of novel, weakly binding inhibitors with scaffolds presenting synthetic opportunities to further optimize biological affinity and lacking development issues associated with the HTS lead. These ROCS-identified scaffolds would have been missed using other structural similarity approaches such as ISIS 2D fingerprints. X-ray crystallographic analysis of one of the new inhibitors bound to ZipA reveals that the shape comparison approach very accurately predicted the binding mode. These experimental results validate this use of ROCS for chemotype switching or "lead hopping" and suggest that it is of general interest for lead identification in drug discovery endeavors.

PubMed: 15743191
DOI: 10.1021/jm040163o

実験手法

X-RAY DIFFRACTION (2 Å)